Track the Standard Biotools INC. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Energy sector, Standard Biotools INC. has published 102 insider filings. Market capitalisation: €357.4m. The latest transaction was reported on 23 June 2026 (Attribution). Among the most active insiders: Casdin Partners Master Fund, L.P.. All data is openly available.
102
Insider Decl.
0
Thresholds
€18m
24 ops.
Buy Volume
€11,670
1 ops.
Sell Volume
27Σ signal
Buys €18m€11,670 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,942 of 25,921 companies
19.4
score / 100
Value
9
Quality
29
FCF yld-24%
Earn yld-22%
EV/EBITDA·
ROE-9.9%
Gross mgn50%
Net mgn-88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
307,900 shares@ US$1.95780.6% of flowCommon StockSEC:0000919574-24-004878:0
Ideal exit: 19 May 2025 (T+270)
25 of 102 declarations
About Standard Biotools INC.
Standard Biotools INC. is a company focused on the energy sector, providing innovative solutions for sustainable development. It is listed on the XNAS market.